These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 29493327)
1. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register. Lundgren C; Lindman H; Rolander B; Ekholm M Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327 [TBL] [Abstract][Full Text] [Related]
2. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer. Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308 [TBL] [Abstract][Full Text] [Related]
3. Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study. Wigertz A; Ahlgren J; Holmqvist M; Fornander T; Adolfsson J; Lindman H; Bergkvist L; Lambe M Breast Cancer Res Treat; 2012 May; 133(1):367-73. PubMed ID: 22286315 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072 [TBL] [Abstract][Full Text] [Related]
5. Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients. He W; Smedby KE; Fang F; Olsson H; Margolin S; Hall P; Czene K J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28423398 [TBL] [Abstract][Full Text] [Related]
6. Factors Influencing Adherence to Adjuvant Endocrine Therapy After Breast Cancer Surgery. Johnsson A; von Wachenfeldt A Cancer Rep (Hoboken); 2024 Aug; 7(8):e2160. PubMed ID: 39158164 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy use among Appalachian breast cancer survivors. Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828 [TBL] [Abstract][Full Text] [Related]
8. Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy. Quinn EM; Fleming C; O'Sullivan MJ Ir J Med Sci; 2016 May; 185(2):383-92. PubMed ID: 25971465 [TBL] [Abstract][Full Text] [Related]
9. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women. Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564 [TBL] [Abstract][Full Text] [Related]
10. Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain. Font R; Espinas JA; Barnadas A; Izquierdo A; Galceran J; Saladie F; Marcos-Gragera R; Torrent A; Manchon-Walsh P; Borras JM Breast Cancer Res Treat; 2019 Jun; 175(3):733-740. PubMed ID: 30887164 [TBL] [Abstract][Full Text] [Related]
11. Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity. Wulaningsih W; Garmo H; Ahlgren J; Holmberg L; Folkvaljon Y; Wigertz A; Van Hemelrijck M; Lambe M Breast Cancer Res Treat; 2018 Nov; 172(1):167-177. PubMed ID: 30030708 [TBL] [Abstract][Full Text] [Related]
12. Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases. Lambert-Côté L; Bouhnik AD; Bendiane MK; Bérenger C; Mondor M; Huiart L; Lauzier S Breast Cancer Res Treat; 2020 Apr; 180(3):777-790. PubMed ID: 32086655 [TBL] [Abstract][Full Text] [Related]
13. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer. He W; Fang F; Varnum C; Eriksson M; Hall P; Czene K J Clin Oncol; 2015 Jul; 33(20):2262-9. PubMed ID: 26033800 [TBL] [Abstract][Full Text] [Related]
14. Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer. Kuba S; Ishida M; Nakamura Y; Taguchi K; Ohno S Breast Cancer; 2016 Jan; 23(1):128-133. PubMed ID: 24934610 [TBL] [Abstract][Full Text] [Related]
15. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090 [TBL] [Abstract][Full Text] [Related]
16. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data. Sheppard VB; He J; Sutton A; Cromwell L; Adunlin G; Salgado TM; Tolsma D; Trout M; Robinson BE; Edmonds MC; Bosworth HB; Tadesse MG J Manag Care Spec Pharm; 2019 May; 25(5):578-586. PubMed ID: 31039059 [TBL] [Abstract][Full Text] [Related]
17. The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence. Neuner JM; Fergestrom NM; Laud PW; Nattinger AB; Beyer KMM; Flynn KE; Pezzin LE Cancer; 2019 Nov; 125(22):3960-3965. PubMed ID: 31373689 [TBL] [Abstract][Full Text] [Related]
18. Adherence to adjuvant endocrine therapy in women with breast cancer. Danilak M; Chambers CR J Oncol Pharm Pract; 2013 Jun; 19(2):105-10. PubMed ID: 22895656 [TBL] [Abstract][Full Text] [Related]
19. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients. Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):812-820. PubMed ID: 30861596 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Lee C; Check DK; Manace Brenman L; Kushi LH; Epstein MM; Neslund-Dudas C; Pawloski PA; Achacoso N; Laurent C; Fehrenbacher L; Habel LA Breast Cancer Res Treat; 2020 Feb; 180(1):219-226. PubMed ID: 31975315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]